Veralto (VLTO) Q4 2025 10-Q Quarterly Report
Filed: Oct 29, 2025Period ending Oct 3, 2025
Health Care
Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR Veralto (VLTO) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Oct 29, 2025 for the fiscal period ending Oct 3, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Veralto Q4 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue $4.107B for nine months ended Oct 3, 2025, up 6.7% YoY from $3.848B nine months ended Sept 27, 2024
- • Operating margin flat YoY at 23.4% for nine months ended Oct 3, 2025 vs 23.4% prior year; Q3 margin decreased to 23.2% from 23.4% YoY
Risk Factors
- • New derivative hedging risk: July 29, 2025, $452M cross-currency swaps to hedge euro and Swiss franc exposure, converting U.S. dollar debt to foreign currency obligations
- • Material update in financial risk: Long-term debt reduced to $1,972M from $2,599M with current portion $700M due 2026, reflecting refinancing and maturity profile changes
Veralto Q4 2025 Quarterly FinancialsXBRL
Revenue
$1.4B
▲ +6.8% YoY▲ +2.4% QoQ
Net Income
$239M
▲ +9.1% YoY▲ +7.7% QoQ
Net Margin
17.0%
▲ +36bp YoY▲ +83bp QoQ
Source: XBRL data from Veralto Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Veralto Quarterly Reports
Get deeper insights on Veralto
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.